Citation Impact
Citing Papers
Probing mucin-type O-linked glycosylation in living animals
2006 StandoutNobel
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
2009 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
Ferroptosis regulation by the NGLY1/NFE2L1 pathway
2022 StandoutNobel
Pharmacological interventions for hypertension in children
2014
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
2009 StandoutNobel
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy
2001 StandoutNobel
Long-Term Trends in the Incidence of and Survival with Heart Failure
2002 Standout
Use of carvedilol in chronic heart failure: Challenges in therapeutic management
1998
Beta-receptor blockade decreases carnitine palmitoyl transferase I activity in dogs with heart failure
1998
Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized study
1995
Changing mortality in dilated cardiomyopathy
1994
Meta-analysis of effect of beta-blocker therapy on mortality in patients with New York Heart Association class IV chronic congestive heart failure
2000
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
1996 Standout
Catalytic Three‐Component Ugi Reaction
2008 StandoutNobel
The Failing Heart — An Engine Out of Fuel
2007 Standout
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
2011 Standout
Prevention of VTE in Orthopedic Surgery Patients
2012 Standout
Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure
2002
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty
2008
Racial Differences in Blood Pressure Response to Angiotensin-Converting Enzyme Inhibitors in Children: A Meta-Analysis
2008
Catalytic Asymmetric Acylcyanation of Imines
2006 StandoutNobel
Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure
1991
Update on the Pharmacologic Treatment of Hypertension in Pediatrics
2012
Myocardial Gene Expression in Dilated Cardiomyopathy Treated with Beta-Blocking Agents
2002
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
β-adrenergic blockade in chronic heart failure: Principles, progress, and practice
1998
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Beta-adrenergic receptor regulation and left ventricular function in idiopathic dilated cardiomyopathy
1993
New Antithrombotic Drugs
2009
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
2011 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
Energy Metabolism in the Normal and Failing Heart: Potential for Therapeutic Interventions
2002
GIPC Interacts with the β1-Adrenergic Receptor and Regulates β1-Adrenergic Receptor-mediated ERK Activation
2003 StandoutNobel
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Efficacy, safety and pharmacokinetics of candesartan cilexetil in hypertensive children from 1 to less than 6 years of age
2010
3 The Medicinal Chemistry of the Azido Group
1994
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
2001 Standout
Selective Intramolecular CH Amination through the Metalloradical Activation of Azides: Synthesis of 1,3‐Diamines under Neutral and Nonoxidative Conditions
2010
Effect of Carvedilol on Survival in Severe Chronic Heart Failure
2001 Standout
Cardiac Resynchronization in Chronic Heart Failure
2002 Standout
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Two functionally distinct α2-adrenergic receptors regulate sympathetic neurotransmission
1999 StandoutNatureNobel
The Management of Chronic Heart Failure
1996
Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure
2004 Standout
Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: A randomized, double-blind, placebo-controlled study
1994
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
2001 Standout
Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade
1995
Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation
2011
Mechanism of Action of Beta-Blocking Agents in Heart Failure
1997
Pharmacological interventions for hypertension in children
2014
Myocardial Reperfusion Injury
2007 Standout
Left Ventricular Remodeling With Carvedilol in Patients With Congestive Heart Failure Due to Ischemic Heart Disease fn1fn1This study was funded by a grant from SmithKline Beecham; however, the study was initiated, conducted, analyzed and reported by the Australia–New Zealand Heart Failure Research Collaborative Group independently of the sponsor. The Clinical Trials Research Unit is supported by a programme grant from the Health Research Council of New Zealand.
1997
Control of Myocardial Contractile Function by the Level of β-Adrenergic Receptor Kinase 1 in Gene-targeted Mice
1998 StandoutNobel
Effects of antihypertensive drugs on blood pressure and proteinuria in childhood
2007
Beneficial effects of metoprolol in heart failure associated with coronary artery disease: A randomized trial
1994
Seven-transmembrane-spanning receptors and heart function
2002 StandoutNatureNobel
Caveolar Localization Dictates Physiologic Signaling of β2-Adrenoceptors in Neonatal Cardiac Myocytes
2002 StandoutNobel
Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents
1993
Reperfusion injury in humans: A review of clinical trials on reperfusion injury inhibitory strategies
2007
Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome
2009
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Dabigatran Etexilate: An Oral Direct Thrombin Inhibitor for Prophylaxis and Treatment of Thromboembolic Diseases
2008
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
1993
Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy
1994
Efficacy, Safety, and Pharmacokinetics of Candesartan Cilexetil in Hypertensive Children Aged 6 to 17 Years
2008
Doxorubicin-Induced Cardiomyopathy
1998 Standout
Safety and efficacy of carvedilol in severe heart failure
1997
Management of metabolic syndrome in children and adolescents
2011
Efficacy and Safety of Extended Release Metoprolol Succinate in Hypertensive Children 6 to 16 Years of Age: A Clinical Trial Experience
2007
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
2000 Standout
Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A–independent activation of Ca2+/calmodulin kinase II
2003 StandoutNobel
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
2012
Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection
2009
Effects of ACE inhibition and β-receptor blockade on energy metabolism in rats postmyocardial infarction
1999
Effect of Amiodarone on Clinical Status and Left Ventricular Function in Patients With Congestive Heart Failure
1996
Dual modulation of cell survival and cell death by β 2 -adrenergic signaling in adult mouse cardiac myocytes
2001 StandoutNobel
The Molecular Basis for Distinct β-Adrenergic Receptor Subtype Actions in Cardiomyocytes
1999
Double-Blind, Placebo-Controlled Study of the Long-term Efficacy of Carvedilol in Patients With Severe Chronic Heart Failure
1995
Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice
1998 StandoutNobel
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
2006 StandoutNobel
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
A Double-Blind, Dose-Response Study of the Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescents with Hypertension
2010
Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction.
1994
Recent Developments in Isocyanide Based Multicomponent Reactions in Applied Chemistry
2005 Standout
β-Adrenergic Receptor Blockade in Chronic Heart Failure
2000
Myocardial Free Fatty Acid and Glucose Use After Carvedilol Treatment in Patients With Congestive Heart Failure
2001
Challenges of Establishing New Antithrombotic Therapies in Atrial Fibrillation
2007
Predictors of Systolic Augmentation From Left Ventricular Preexcitation in Patients With Dilated Cardiomyopathy and Intraventricular Conduction Delay
2000
Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A–independent activation of Ca2+/calmodulin kinase II
2003 StandoutNobel
Left Ventricular or Biventricular Pacing Improves Cardiac Function at Diminished Energy Cost in Patients With Dilated Cardiomyopathy and Left Bundle-Branch Block
2000
Double-Blind, Placebo-Controlled Study of the Effects of Carvedilol in Patients With Moderate to Severe Heart Failure
1996
An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.
2001
A Rapid Access to Biaryl Ether Containing Macrocycles by Pairwise Use of Ugi 4CR and Intramolecular SNAr-Based Cycloetherification
2001
Restoration of β-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer
1997 StandoutNobel
Katalytische, enantioselektive Synthese vonα-Aminonitrilen mit einem neuartigen Zirconiumkatalysator
1998
Intracoronary Adenovirus-Mediated Delivery and Overexpression of the β 2 -Adrenergic Receptor in the Heart
2000 StandoutNobel
In Vitro and In Vivo Characterization of Intrinsic Sympathomimetic Activity in Normal and Heart Failure Rats
1999
Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure
2001 StandoutNobel
Rapid and diverse route to natural product-like biaryl ether containing macrocycles
2003
Reciprocal In Vivo Regulation of Myocardial G Protein–Coupled Receptor Kinase Expression by β-Adrenergic Receptor Stimulation and Blockade
1998 StandoutNobel
Carvedilol Inhibits Clinical Progression in Patients With Mild Symptoms of Heart Failure
1996
Efficacy and Safety of the Angiotensin Receptor Blocker Valsartan in Children With Hypertension Aged 1 to 5 Years
2008
The Role of ??-Blockers in the Treatment of Cardiomyopathy and Ischaemic Heart Failure
1994
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators.
1994
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
2013
Clinical Effects of β-Adrenergic Blockade in Chronic Heart Failure
1998
Medical Therapy Can Improve the Biological Properties of the Chronically Failing Heart
1996
Preservation of myocardial β-adrenergic receptor signaling delays the development of heart failure after myocardial infarction
2000 StandoutNobel
Enzyme-Controlled Nitrogen-Atom Transfer Enables Regiodivergent C–H Amination
2014 StandoutNobel
Screening for Hypertension in Children and Adolescents to Prevent Cardiovascular Disease
2013
Works of David Deitchman being referenced
Long-term (2 year) beneficial effects of beta-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathy
1991
Effects of bucindolol on neurohormonal activation in congestive heart failure
1991
A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer
2012
Long-term β-Blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: A double-blind, randomized study of bucindolol versus placebo
1990
The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacement
2007
Racial differences are seen in blood pressure response to fosinopril in hypertensive children
2006
Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction.
1994
β-adrenoceptor and cardiovascular effects of MJ 13105 (Bucindolol) in anesthetized dogs and rats
1980
Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy.
1991
Sulfamoyl azides. Hydrolysis rates and hypotensive activity
1972
Antihypertensive agents. Synthesis and biological properties of 2-amino-4-aryl-2-imidazolines
1973
OC-03 Randomized phase II trial of an oral factor Xa inhibitor in patients with metastatic cancer on chemotherapy
2010
Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose‐ranging study
2008
Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol.
1990
Is the Extrapolated Adult Dose of Fosinopril Safe and Effective in Treating Hypertensive Children?
2004
A Phase II Randomized, Double-Blind, Eight-Arm, Parallel-Group, Dose-Response Study of Apixaban, a New Oral Factor Xa Inhibitor for the Prevention of Deep Vein Thrombosis in Knee Replacement Surgery - On Behalf of the Apixaban Investigators.
2006
A randomized phase II trial of a new anticoagulant, apixaban, in metastatic cancer
2009